Jim Tananbaum is the founder and the CEO of Foresite Capital with assets estimated to be $1.1billion. He has more than 20years of experience building healthcare companies. Jim graduated from Yale with BS, Math, Computer Science, He later went to Harvard Medical School and graduated with a Doctorate of Medicine, he also obtained a Masters in Science (Information Theory) from Massachusetts Institute of Technology and a Master of Business Administration from Harvard Business School.

Before founding the Foresite Capital, he Co-founded several biopharmaceutical companies and two healthcare investment practices. After exiting Harvard Medical School, he established the Geltex Company. The Company brought in two drugs into the market that generated over $1 billion in revenue. He also founded Theravance, Inc which has a market cap of $2.75 billion. Earlier, Mr. Jim Tananbaum helped Siera Ventures establish a healthcare service as an investment. He has led in other numerous investments such as Amerigroup, Healtheon, Jazz Pharmaceuticals and Amira Pharmaceuticals.

Recent Works

According to Patient Daily, in his recent venture, Jim Tananbaum’s company the Foresite together with Optum Ventures and Arch Ventures Partners jointly raised funds of up to $14 million for Mindstrong Health. Mindstrong Health is a startup that uses mainly smartphones to help in the treatment of mental disorders. Mindstrong has developed a platform where it uses the patient’s pattern of typing and scrolling to measure the brain function. Check out LinkedIn to know more.

In a report by Market Wired, the platform provides information about cognition biomarkers, a mood which includes processing speed, function, and memory. The founder of Mindstrong said that the modern medicine is based on objective measures like for other illnesses like heart disease and diabetes. It improves mental treatment as it has been limited to only subjective reports.In his speech, Jim Tananbaum said that Mindstrong Health’s founding team brings an unmatched understanding of the challenges surrounding the way the medical fraternity cares for people suffering from cognitive health disorders.

Read more: